
Team
Our team is committed to developing transformative therapies that decrease the burden of disease and increase healthspan on a population-level scale
Leadership
Board
Advisors

Kristen Fortney, PhD
Co-Founder, CEO

Eric Morgen, MD
Co-Founder, COO

Paul Rubin, MD
CMO & EVP, Research

Peng Leong, PhD, MBA
Chief Business Officer & Therapeutic Area Head, Brain Aging

Ann Neale
Chief Development Officer

Dov Goldstein, MD, MBA
Chief Financial Officer

BJ Sullivan, PhD
Chief Strategy Officer

Patrick Martin, MD
SVP, Clinical Science

Julie Gammelgard
SVP, People

Sabine Vukelich, PhD
SVP, Regulatory Affairs & QA

Rusty Montgomery, PhD
SVP, Research

Robert Hughes, PhD
Senior Fellow

Chris Patil, PhD
VP, Media

Ralph Scarborough
VP, Finance & Accounting

Sanjeev Kothari, PhD
VP, CMC

Naisha Shah, PhD
VP, Data Science

Yan Wang
VP, Translational Aging Biology

Kristen Fortney, PhD
Co-Founder, CEO

Eric Morgen, MD
Co-Founder, COO

Vijay Pande, PhD
Professor at Stanford, Partner at a16z

Jason Coloma, PhD, MBA
Independent Director

Rekha Hemrajani, MBA
Independent Director
George Hartman, PhD
Sr.Advisor, Chemistry
Klaus Klumpp, PhD
Sr.Advisor, Drug Discovery
Elad Gil, PhD
Advisor, Biotechnology
Joe Betts-LaCroix
Advisor, Biotechnology
Eric Verdin, MD
Advisor, Aging
William J. Evans, PhD
Advisor, Muscle Aging
Mark Perrone, PhD
Advisor, Pharmacology
Peter Dilaura
Advisor, Biotechnology
Pankaj Agarwal, PhD
Advisor, Drug Discovery Bioinformatics
Bradley Willcox, MD
Advisor, Biobanks
Tõnu Esko, PhD
Advisor, Biobanks
Kristen leads BIOAGE in its mission to develop a broad pipeline of therapies that target aging in order to increase healthspan and address chronic diseases. Kristen draws from a deep background in aging research and systems biology to develop BIOAGE’s data-driven approach to identify and target the molecular pathways that drive aging. Kristen received her PhD in Medical Biophysics from the University of Toronto, followed by postdoctoral training at Stanford University where she was a fellow of the Ellison Medical Foundation / American Federation for Aging Research. She has over 10 years of experience developing novel bioinformatics approaches for data-driven investigation into the mechanisms of aging and age-related disease, with 18 published papers spanning computational drug discovery, biomarkers of aging, and the genetics of exceptional human longevity.